- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Panic Disorder Severity Scale.
Displaying page 1 of 1.
EudraCT Number: 2007-001060-80 | Sponsor Protocol Number: AB/PD/21 | Start Date*: 2007-10-11 | |||||||||||
Sponsor Name:ABIOGEN PHARMA | |||||||||||||
Full Title: A multicenter, parallel-group, double-blind, randomized, placebo-controlled, increasing-dose study, to evaluate preliminarily the clinical effects, the safety and tolerability of ABIO 08/01, in pat... | |||||||||||||
Medical condition: Panic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021198-35 | Sponsor Protocol Number: 32820 | Start Date*: 2010-09-02 | |||||||||||
Sponsor Name:University Utrecht | |||||||||||||
Full Title: D-cycloserine (DCS) enhancement of exposure therapy in panic disorder with agoraphobia: a randomized controlled trial. | |||||||||||||
Medical condition: panic disorder with agoraphobia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003191-39 | Sponsor Protocol Number: | Start Date*: 2013-01-21 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: The effect of a single-dose of d-cycloserine on the basic effects of cognitive-behaviour therapy for panic disorder - a randomized placebo-controlled trial | |||||||||||||
Medical condition: DSM-IV Panic disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005708-17 | Sponsor Protocol Number: ELB139202-05 | Start Date*: 2006-03-27 | |||||||||||
Sponsor Name:elbion AG | |||||||||||||
Full Title: International, multicenter, randomized, double-blind, placebo controlled, two-period, cross-over study to demonstrate safety, tolerability and anxiolytic effects of 600 mg ELB139 given orally t.i.d... | |||||||||||||
Medical condition: Male and female patients with diagnosis of concurrent panic disorder according to DSM-IV, with or without agoraphobia (DSM IV 300.21 and 300.1) according to Mini International Neuropsychiatric Inte... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002649-19 | Sponsor Protocol Number: 7043 | Start Date*: 2010-04-07 |
Sponsor Name:Tartu University Hospital Psychiatry Clinic | ||
Full Title: Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorder | ||
Medical condition: panic disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: EE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-001398-19 | Sponsor Protocol Number: Exposition-DCS | Start Date*: 2011-06-27 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: D-cycloserine augmented exposure therapy in patients with agoraphobia | ||
Medical condition: agarophobia with or without panic disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004094-17 | Sponsor Protocol Number: 40-41200-98-9269 | Start Date*: 2015-11-03 | |||||||||||
Sponsor Name:Universiteit Utrecht | |||||||||||||
Full Title: Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias. | |||||||||||||
Medical condition: Phobic anxiety disorders: either generalized social phobia or panic disorder with agoraphobia. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001683-29 | Sponsor Protocol Number: 61393215MDD2001 | Start Date*: 2019-09-27 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: Double-Blind, Placebo-Controlled, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-61393215 as Adjunctive Treatment in Adults with Major Depressive Disorder with Anxio... | |||||||||||||
Medical condition: Adjunctive Treatment in Adults with Major Depressive Disorder with Anxious Distress with Suboptimal Response to Standard Antidepressants | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001718-26 | Sponsor Protocol Number: DFI10560 | Start Date*: 2010-05-07 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of t... | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022914-15 | Sponsor Protocol Number: A3051123 | Start Date*: 2012-03-01 | |||||||||||
Sponsor Name:Pfizer, S.L.U. | |||||||||||||
Full Title: A PHASE 4, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO -CONTROLLED, MULTICENTER STUDY EVALUATING THE NEUROPSYCHIATRIC SAFETY AND EFFICACY OF 12 WEEKS VARENICLINE TARTRATE 1MG BID AND BUPROPION HYD... | |||||||||||||
Medical condition: Nicotine Addiction with the desire to quit smoking | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) DK (Completed) FI (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
